Correlation Between BioSig Technologies, and Heart Test

Can any of the company-specific risk be diversified away by investing in both BioSig Technologies, and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioSig Technologies, and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between BioSig Technologies, Common and Heart Test Laboratories, you can compare the effects of market volatilities on BioSig Technologies, and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioSig Technologies, with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioSig Technologies, and Heart Test.

Diversification Opportunities for BioSig Technologies, and Heart Test

0.56

Correlation Coefficient

BioSig Technologies,  Heart Test

Very weak diversification

The 3 months correlation between BioSig and Heart is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding BioSig Technologies, Common and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and BioSig Technologies, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioSig Technologies, Common are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of BioSig Technologies, i.e., BioSig Technologies, and Heart Test go up and down completely randomly.

Pair Corralation between BioSig Technologies, and Heart Test

Given the investment horizon of 90 days BioSig Technologies, Common is expected to under-perform the Heart Test. In addition to that, BioSig Technologies, is 2.33 times more volatile than Heart Test Laboratories. It trades about -0.16 of its total potential returns per unit of risk. Heart Test Laboratories is currently generating about -0.11 per unit of volatility. If you would invest  381.00  in Heart Test Laboratories on December 27, 2024 and sell it today you would lose (96.53) from holding Heart Test Laboratories or give up 25.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	98.36%
Values	Daily Returns

BioSig Technologies, Common  vs.  Heart Test Laboratories

BioSig Technologies,

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioSig Technologies, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Heart Test Laboratories

Risk-Adjusted Performance

Very Weak

Over the last 90 days Heart Test Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with BioSig Technologies, and Heart Test

The main advantage of trading using opposite BioSig Technologies, and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioSig Technologies, position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.

The idea behind BioSig Technologies, Common and Heart Test Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.